LaSalle St. Investment Advisors’s Boston Scientific BSX Stock Holding History

LaSalle St. Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,575	Closed	-$287K	–	433
2026 Q1	$287K	Sell	4,575 -57	-1%	-$4.56K	0.04%	306
2025 Q4	$441K	Buy	4,632 +142	+3%	+$13.9K	0.07%	202
2025 Q3	$438K	Buy	4,490 +698	+18%	+$72.3K	0.08%	193
2025 Q2	$407K	Buy	3,792 +207	+6%	+$20.9K	0.11%	180
2025 Q1	$361K	Buy	3,585 +395	+12%	+$39.8K	0.09%	189
2024 Q4	$284K	Buy	3,190 +545	+21%	+$48K	0.09%	204
2024 Q3	$221K	Buy	+2,645	New	+$209K	0.09%	187

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

LaSalle St. Investment Advisors's BSX Position: Q2 2026 in Review

LaSalle St. Investment Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,575 shares — an estimated $287K sold.

LaSalle St. Investment Advisors first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $441K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

LaSalle St. Investment Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
LaSalle St. Investment Advisors sold 4,575 Boston Scientific shares in Q2 2026, an estimated $287K.
LaSalle St. Investment Advisors first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
LaSalle St. Investment Advisors's Boston Scientific position peaked at $441K in Q4 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.